Folate-Based Radiotracers for PET Imaging—Update and Perspectives

por Müller, Cristina
Publicado 2013

Prospects in Folate Receptor-Targeted Radionuclide Therapy

por Müller, Cristina, Schibli, Roger
Publicado 2013

Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk?

por Müller, Cristina, Schibli, Roger, Maurer, Britta
Publicado 2020

Impact of the mouse model and molar amount of injected ligand on the tissue distribution profile of PSMA radioligands

por Tschan, Viviane J., Borgna, Francesca, Schibli, Roger, Müller, Cristina
Publicado 2021

Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization

por Siwowska, Klaudia, Schmid, Raffaella M., Cohrs, Susan, Schibli, Roger, Müller, Cristina
Publicado 2017

Pain intensity and cervical range of motion in women with myofascial pain treated with acupuncture and electroacupuncture: a double-blinded, randomized clinical trial

por Aranha, Maria F. M., Müller, Cristina E. E., Gavião, Maria B. D.
Publicado 2015

Combining Albumin-Binding Properties and Interaction with Pemetrexed to Improve the Tissue Distribution of Radiofolates

por Müller, Cristina, Guzik, Patrycja, Siwowska, Klaudia, Cohrs, Susan, Schmid, Raffaella M., Schibli, Roger
Publicado 2018

Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application

por Müller, Cristina, Domnanich, Katharina A, Umbricht, Christoph A, van der Meulen, Nicholas P
Publicado 2018

Active bone marrow S-values for the low-energy electron emitter terbium-161 compared to S-values for lutetium-177 and yttrium-90

por Hemmingsson, Jens, Svensson, Johanna, van der Meulen, Nicholas P., Müller, Cristina, Bernhardt, Peter
Publicado 2022

A Short-Term Biological Indicator for Long-Term Kidney Damage after Radionuclide Therapy in Mice

por Pellegrini, Giovanni, Siwowska, Klaudia, Haller, Stephanie, Antoine, Daniel J., Schibli, Roger, Kipar, Anja, Müller, Cristina
Publicado 2017

Promising potential of [(177)Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy—a preclinical study using a syngeneic breast cancer model

por Guzik, Patrycja, Siwowska, Klaudia, Fang, Hsin-Yu, Cohrs, Susan, Bernhardt, Peter, Schibli, Roger, Müller, Cristina
Publicado 2020

[(225)Ac]Ac-SibuDAB for Targeted Alpha Therapy of Prostate Cancer: Preclinical Evaluation and Comparison with [(225)Ac]Ac-PSMA-617

por Busslinger, Sarah D., Tschan, Viviane J., Richard, Olivia K., Talip, Zeynep, Schibli, Roger, Müller, Cristina
Publicado 2022

Preclinical in vivo application of $^{152}$Tb-DOTANOC: a radiolanthanide for PET imaging

por Müller, Cristina, Vermeulen, Christiaan, Johnston, Karl, Köster, Ulli, Schmid, Raffaella, Türler, Andreas, van der Meulen, Nicholas P
Publicado 2016

Preclinical in vivo application of (152)Tb-DOTANOC: a radiolanthanide for PET imaging

por Müller, Cristina, Vermeulen, Christiaan, Johnston, Karl, Köster, Ulli, Schmid, Raffaella, Türler, Andreas, van der Meulen, Nicholas P.
Publicado 2016

Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics

por Müller, Cristina, Vermeulen, Christiaan, Köster, Ulli, Johnston, Karl, Türler, Andreas, Schibli, Roger, van der Meulen, Nicholas P.
Publicado 2016

Albumin-Binding PSMA Radioligands: Impact of Minimal Structural Changes on the Tissue Distribution Profile

por Deberle, Luisa M., Tschan, Viviane J., Borgna, Francesca, Sozzi-Guo, Fan, Bernhardt, Peter, Schibli, Roger, Müller, Cristina
Publicado 2020

Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates—new perspectives for folate receptor–targeted radionuclide therapy

por Guzik, Patrycja, Benešová, Martina, Ratz, Magdalena, Monné Rodríguez, Josep M., Deberle, Luisa M., Schibli, Roger, Müller, Cristina
Publicado 2020

Folate Receptor Targeted Alpha-Therapy Using Terbium-149

por Müller, Cristina, Reber, Josefine, Haller, Stephanie, Dorrer, Holger, Köster, Ulli, Johnston, Karl, Zhernosekov, Konstantin, Türler, Andreas, Schibli, Roger
Publicado 2014

Terbium-149 for targeted alpha therapy

por Borgna, Francesca, Favaretto, Chiara, Grundler, Pascal, Johnston, Karl, Köster, Ulli, Müller, Cristina, Talip, Zeynep, van der Meulen, Nick
Publicado 2021

PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with (177)Lu-DOTA-bombesin analogues

por Däpp, Simone, Müller, Cristina, Garayoa, Elisa García, Bläuenstein, Peter, Maes, Veronique, Brans, Luc, Tourwé, Dirk A, Schibli, Roger
Publicado 2012